| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.27B | 93.67B | 100.84B | 88.65B | 87.46B | 57.02B |
| Gross Profit | 48.61B | 49.20B | 48.42B | 37.45B | 40.97B | 26.69B |
| EBITDA | 33.09B | 31.78B | 33.22B | 24.15B | 29.27B | 18.71B |
| Net Income | 23.55B | 25.07B | 23.62B | 18.80B | 20.90B | 12.82B |
Balance Sheet | ||||||
| Total Assets | 184.36B | 202.27B | 190.98B | 162.74B | 150.51B | 126.88B |
| Cash, Cash Equivalents and Short-Term Investments | 78.07B | 92.93B | 82.57B | 79.09B | 67.01B | 60.30B |
| Total Debt | 4.22B | 0.00 | 106.00M | 112.00M | 82.00M | 598.00M |
| Total Liabilities | 34.52B | 31.23B | 37.78B | 31.02B | 36.05B | 30.84B |
| Stockholders Equity | 149.84B | 171.04B | 153.20B | 131.71B | 114.50B | 96.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.17B | 26.46B | 16.10B | 15.06B | 14.76B |
| Operating Cash Flow | 0.00 | 16.95B | 27.16B | 16.28B | 15.26B | 15.07B |
| Investing Cash Flow | 0.00 | 989.00M | -5.54B | -4.54B | -2.95B | -15.39B |
| Financing Cash Flow | 0.00 | -9.15B | -6.44B | -6.41B | -4.54B | -2.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥413.91B | 15.76 | ― | 0.33% | 3.01% | 47.38% | |
75 Outperform | ¥1.08T | 72.64 | 11.19% | 1.12% | 15.16% | 20.06% | |
73 Outperform | ¥540.42B | 21.16 | ― | 1.12% | -7.11% | 6.18% | |
68 Neutral | ¥54.60B | 14.25 | 4.10% | 4.16% | 11.30% | 245.85% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥29.08B | 9.01 | ― | 1.11% | -2.51% | -0.60% | |
55 Neutral | ¥144.75B | 139.47 | ― | 0.26% | 17.00% | ― |